TLR2 and neoplasm: In both breast cancer and Lewis lung carcinoma, the presence of versican produced by the tumor cells leads to an accumulation and activation of tumor-associated macrophages (TAMs) via TLR2 and its co-receptors TLR6 and CD14 (118, 119, 159, 165–167).